J&J | JNJ - Ordinary Share Capital




J&J reported $3.12B in Ordinary Share Capital for its fiscal quarter ending in September of 2024.

Ordinary Share Capital Change Date
AbbVie USD 18M 0 Sep/2024
Abbott USD 25.02B 408M Sep/2024
Amgen USD 33.39B 189M Sep/2024
AstraZeneca USD 388M 0 Sep/2024
Baxter International USD 683M 0 Sep/2024
Bayer EUR 2.52B 0 Sep/2024
Becton, Dickinson and Co. USD 371M 0 Sep/2024
Biogen USD 100K 0 Sep/2024
Boston Scientific USD 17M 0 Sep/2024
Bristol-Myers Squibb USD 292M 0 Sep/2024
CONMED USD 313K 0 Sep/2024
Cooper Companies USD 21.7M 0 Oct/2024
Dexcom USD 400K 0 Sep/2024
Edwards Lifesciences USD 653.5M 1.7M Jun/2024
Eli Lilly USD 593.9M 300K Sep/2024
Gilead Sciences USD 1000K 0 Jun/2024
GlaxoSmithKline GBP 1.35B 0 Sep/2024
Globus Medical USD 135K 0 Sep/2024
Hologic USD 3M 0 Sep/2024
Indivior 67M 1000K Jun/2024
Insulet USD 100K 0 Jun/2024
Integra LifeSciences USD 916K 0 Sep/2024
Intuitive Surgical USD 400K 0 Sep/2024
J&J USD 3.12B 0 Sep/2024
Medtronic USD 128K 0 Oct/2024
Merck USD 1.79B 0 Jun/2024
Merit Medical Systems USD 669.21M 10.48M Sep/2024
Novartis USD 793M 32M Sep/2024
Regeneron Pharmaceuticals USD 100K 2K Sep/2024
Roche Holding CHF 107M 0 Jun/2024
Stryker USD 38M 0 Jun/2024
Tandem Diabetes Care USD 66K 1000 Sep/2024
Teva Pharmaceutical Industries USD 1.13K 57M Mar/2024
Vertex Pharmaceuticals USD 2.6M 0 Jun/2024
Zimmer Biomet Holdings USD 3.2M 0 Sep/2023
Zoetis USD 5M 0 Sep/2024